Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition
Aim: To characterize, by means of univariate and multivariate approaches, the T helper (Th)-1 and Th-2 responses during the different phases of tumor immunoediting. Materials & methods: We used a multivariate principal component analysis applied to analyze the joint behavior of serum concentrati...
| Autores: | , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2020 |
| País: | Argentina |
| Institución: | Consejo Nacional de Investigaciones Científicas y Técnicas |
| Repositorio: | CONICET Digital (CONICET) |
| Idioma: | inglés |
| OAI Identifier: | oai:ri.conicet.gov.ar:11336/174627 |
| Acceso en línea: | http://hdl.handle.net/11336/174627 |
| Access Level: | acceso abierto |
| Palabra clave: | CANCER IMMUNOEDITING MAMMARY ADENOCARCINOMA MATHEMATICAL MODEL https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
| id |
AR_1f8a7da99b153333cc8c1e953d76091c |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/174627 |
| network_acronym_str |
AR |
| network_name_str |
Argentina |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition |
| title |
Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition |
| spellingShingle |
Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition del Giúdice, Antonela CANCER IMMUNOEDITING MAMMARY ADENOCARCINOMA MATHEMATICAL MODEL https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
| title_short |
Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition |
| title_full |
Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition |
| title_fullStr |
Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition |
| title_full_unstemmed |
Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition |
| title_sort |
Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition |
| dc.creator.none.fl_str_mv |
del Giúdice, Antonela Pagura, Lucas Capitani, María Celeste Mainetti, Leandro Ernesto Scharovsky, Olga Graciela Di Masso, Ricardo Jose Rico, Maria Jose Rozados, Viviana Rosa |
| author |
del Giúdice, Antonela |
| author_facet |
del Giúdice, Antonela Pagura, Lucas Capitani, María Celeste Mainetti, Leandro Ernesto Scharovsky, Olga Graciela Di Masso, Ricardo Jose Rico, Maria Jose Rozados, Viviana Rosa |
| author_role |
author |
| author2 |
Pagura, Lucas Capitani, María Celeste Mainetti, Leandro Ernesto Scharovsky, Olga Graciela Di Masso, Ricardo Jose Rico, Maria Jose Rozados, Viviana Rosa |
| author2_role |
author author author author author author author |
| dc.subject.none.fl_str_mv |
CANCER IMMUNOEDITING MAMMARY ADENOCARCINOMA MATHEMATICAL MODEL https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
| topic |
CANCER IMMUNOEDITING MAMMARY ADENOCARCINOMA MATHEMATICAL MODEL https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
| description |
Aim: To characterize, by means of univariate and multivariate approaches, the T helper (Th)-1 and Th-2 responses during the different phases of tumor immunoediting. Materials & methods: We used a multivariate principal component analysis applied to analyze the joint behavior of serum concentrations of IFN-γ, IL-2, IL-10 and IL-4, during the different phases of tumor immunoediting, in CBi/L mice challenged with M-406 mammary adenocarcinoma. Results & conclusion: Animals in equilibrium phase showed the widest variations in values of the four cytokines. In this experimental model, the role of IFN-γwould be related to tumor growth and progression, while IL-10 would participate in the antitumor immune response. Lay abstract Breast cancer is a complex, multifactor disease that affects about 10% of women in industrialized countries. The immune system has the ability to monitor the appearance of tumors, but the tumors have the ability to escape such rejection. For this reason, in order to design different therapeutic strategies, it is important to know the different mechanisms that take place when a tumor grows or when it is rejected. Here we sought to elucidate some of these mechanisms. |
| publishDate |
2020 |
| dc.date.none.fl_str_mv |
2020-12 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/174627 del Giúdice, Antonela; Pagura, Lucas; Capitani, María Celeste; Mainetti, Leandro Ernesto; Scharovsky, Olga Graciela; et al.; Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition; Future Medicine; Future Science OA; 6; 10; 12-2020; 1-16 2056-5623 CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/174627 |
| identifier_str_mv |
del Giúdice, Antonela; Pagura, Lucas; Capitani, María Celeste; Mainetti, Leandro Ernesto; Scharovsky, Olga Graciela; et al.; Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition; Future Medicine; Future Science OA; 6; 10; 12-2020; 1-16 2056-5623 CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.future-science.com/doi/10.2144/fsoa-2019-0108 info:eu-repo/semantics/altIdentifier/doi/10.2144/fsoa-2019-0108 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Future Medicine |
| publisher.none.fl_str_mv |
Future Medicine |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1799194659420897280 |
| spelling |
Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoeditiondel Giúdice, AntonelaPagura, LucasCapitani, María CelesteMainetti, Leandro ErnestoScharovsky, Olga GracielaDi Masso, Ricardo JoseRico, Maria JoseRozados, Viviana RosaCANCER IMMUNOEDITINGMAMMARY ADENOCARCINOMAMATHEMATICAL MODELhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Aim: To characterize, by means of univariate and multivariate approaches, the T helper (Th)-1 and Th-2 responses during the different phases of tumor immunoediting. Materials & methods: We used a multivariate principal component analysis applied to analyze the joint behavior of serum concentrations of IFN-γ, IL-2, IL-10 and IL-4, during the different phases of tumor immunoediting, in CBi/L mice challenged with M-406 mammary adenocarcinoma. Results & conclusion: Animals in equilibrium phase showed the widest variations in values of the four cytokines. In this experimental model, the role of IFN-γwould be related to tumor growth and progression, while IL-10 would participate in the antitumor immune response. Lay abstract Breast cancer is a complex, multifactor disease that affects about 10% of women in industrialized countries. The immune system has the ability to monitor the appearance of tumors, but the tumors have the ability to escape such rejection. For this reason, in order to design different therapeutic strategies, it is important to know the different mechanisms that take place when a tumor grows or when it is rejected. Here we sought to elucidate some of these mechanisms.Fil: del Giúdice, Antonela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario; Argentina. Universidad Nacional de Rosario. Facultad de Ciencias Médicas. Instituto de Genética Experimental. Sección de Oncología Experimental; ArgentinaFil: Pagura, Lucas. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario; Argentina. Universidad Nacional de Rosario. Facultad de Ciencias Médicas. Instituto de Genética Experimental. Sección de Oncología Experimental; ArgentinaFil: Capitani, María Celeste. Universidad Nacional de Rosario. Facultad de Ciencias Médicas. Instituto de Genética Experimental. Sección de Oncología Experimental; ArgentinaFil: Mainetti, Leandro Ernesto. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario; Argentina. Universidad Nacional de Rosario. Facultad de Ciencias Médicas. Instituto de Genética Experimental. Sección de Oncología Experimental; ArgentinaFil: Scharovsky, Olga Graciela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario; Argentina. Universidad Nacional de Rosario. Facultad de Ciencias Médicas. Instituto de Genética Experimental. Sección de Oncología Experimental; Argentina. Universidad Nacional de Rosario. Consejo de Investigaciones de la Universidad de Rosario; ArgentinaFil: Di Masso, Ricardo Jose. Universidad Nacional de Rosario. Facultad de Ciencias Médicas. Instituto de Genética Experimental. Sección de Oncología Experimental; ArgentinaFil: Rico, Maria Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario; Argentina. Universidad Nacional de Rosario. Facultad de Ciencias Médicas. Instituto de Genética Experimental. Sección de Oncología Experimental; ArgentinaFil: Rozados, Viviana Rosa. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario; Argentina. Universidad Nacional de Rosario. Facultad de Ciencias Médicas. Instituto de Genética Experimental. Sección de Oncología Experimental; ArgentinaFuture Medicine2020-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/174627del Giúdice, Antonela; Pagura, Lucas; Capitani, María Celeste; Mainetti, Leandro Ernesto; Scharovsky, Olga Graciela; et al.; Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition; Future Medicine; Future Science OA; 6; 10; 12-2020; 1-162056-5623CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.future-science.com/doi/10.2144/fsoa-2019-0108info:eu-repo/semantics/altIdentifier/doi/10.2144/fsoa-2019-0108info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2024-05-08T13:33:43Zoai:ri.conicet.gov.ar:11336/174627instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982024-05-08 13:33:43.754CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| score |
15,811543 |